Document is current
Any future updates will be listed below
-
Authors
-
Funding
Funding for this research was provided by:
H. Lundbeck A/S
- License Information
-
More Information
Article History
Received: 7 April 2025
Accepted: 8 May 2025
First Online: 27 May 2025
Declarations
:
: Dawn C. Buse has been a consultant for AbbVie, Amgen, Biohaven, Collegium, Lilly, Lundbeck, Pfizer, Teva and Theranica. Jan Versijpt received personal fees and non-financial support from Medtronic, Pfizer and Teva; personal fees from Lundbeck and Novartis; and grants and non-financial support from Allergan/AbbVie. Hans-Christoph Diener received honoraria for participation in clinical trials, advisory boards and presentations for AbbVie, Lilly, Lundbeck, Novartis, Orion Pharma, Pfizer, Teva and WebMD.
: This article is based on previously conducted studies and does not contain any new studies with human participants or animals performed by any of the authors.
